The Pandora’s box has been opened in the twenty-first century unleashing “the Coronavirus.” There has been an increase in the incidence of mucormycosis during this coronavirus disease 2019 (COVID-19) pandemic with many case reports of rhino-orbito-cerebral and pulmonary mucormycosis. Diabetes mellitus, COVID, and Mucor fungus together are a dangerous trio associated with high mortality. We report a rare case of renal mucormycosis following COVID pneumonia in a 64-year-old patient with uncontrolled diabetes;
Keywords: COVID-19, Diabetes, Renal Mucormycosis
Introduction
The coronavirus disease 2019 (COVID-19) pandemic continues despite affecting more than 196 million cases and claiming more than 4.2 million lives globally.1 Adding to the disease burden, we also have incidences of opportunistic fungal infections including aspergillosis, candidiasis, and mucormycosis in patients either after recovery or during the resolving phase of COVID-19 pneumonia.2 There has been a surge of the COVID-19-associated mucormycosis (CAM) especially in India.3